Clinical Trial Update: Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating avelumab for chemo-resistant gestational trophoblastic neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Gestational Trophoblastic Neoplasias (GTN) | Phase 2 | Status: COMPLETED